Arranon and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Arranon (nelarabine), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Bortezomib, and have T-cell type acute leukaemia.

The phase IV clinical study analyzes which people have Fall when taking Arranon. It is created by eHealthMe based on reports of 288 people who have side effects when taking Arranon from the FDA, and is updated regularly.

What is Arranon?

Arranon has active ingredients of nelarabine. eHealthMe is studying from 289 Arranon users. Check the latest studies of Arranon.

What is Fall?

Fall is found to be associated with 3,286 drugs and 3,749 conditions by eHealthMe. Check the latest studies of Fall.

On Sep, 24, 2025

288 people reported to have side effects when taking Arranon.
Among them, 8 people (2.78%) have Fall.

Among these 8 people:

How long have people been on Arranon when they have Fall? *

What is the gender of people who have Fall when taking Arranon? *

female: 25 %
male: 75 %

What is the age of people who have Fall when taking Arranon? *

What are other drugs people take besides Arranon? *

Bortezomib: 4 people, 50.00%
Melphalan Hydrochloride: 3 people, 37.50%
Fludarabine Phosphate: 3 people, 37.50%
Cytarabine: 3 people, 37.50%
Cyclophosphamide: 3 people, 37.50%
Oncovin: 2 people, 25.00%
Fentanyl: 2 people, 25.00%
Mycophenolate Mofetil: 1 person, 12.50%
Methylprednisolone: 1 person, 12.50%
Etoposide: 1 person, 12.50%

What are other side effects people have besides Fall? *

Weakness: 8 people, 100.00%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 4 people, 50.00%
Decreased Vibratory Sense: 4 people, 50.00%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 50.00%
Muscle Atrophy (a decrease in the mass of the muscle): 4 people, 50.00%
Areflexia (absence of a reflex): 3 people, 37.50%
Breathing - Slowed Or Stopped: 3 people, 37.50%
Dyspnea (difficult or laboured breathing): 3 people, 37.50%
Nerve Conduction Studies Abnormal: 3 people, 37.50%
Monoplegia (a paralysis of a single limb): 3 people, 37.50%

What are the existing conditions these people have? *

T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 5 people, 62.50%
Rashes (redness): 2 people, 25.00%
Precursor T-Lymphoblastic Lymphoma/leukaemia (precursor b-cell cancer): 2 people, 25.00%
Cancer Pain: 2 people, 25.00%
Neoplasm Malignant (cancer tumour): 1 person, 12.50%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Arranon and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arranon:

Arranon (289 reports)

Fall treatments and more:

Fall (403,513 reports)

How severe was Fall and when was it recovered:

Fall in Arranon

Browse all side effects of Arranon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,286 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,749 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nelarabine (the active ingredients of Arranon) and Arranon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.